These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 15184196)
1. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Fautrel B; Sibilia J; Mariette X; Combe B; Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196 [TBL] [Abstract][Full Text] [Related]
2. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Kakkassery V; Mergler S; Pleyer U Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052 [TBL] [Abstract][Full Text] [Related]
3. [Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center]. de Oliveira SK; de Almeida RG; Fonseca AR; Rodrigues MC; Sztajnbok F; Diniz C Acta Reumatol Port; 2007; 32(2):139-50. PubMed ID: 17572652 [TBL] [Abstract][Full Text] [Related]
4. Etanercept in the treatment of adult patients with Still's disease. Husni ME; Maier AL; Mease PJ; Overman SS; Fraser P; Gravallese EM; Weinblatt ME Arthritis Rheum; 2002 May; 46(5):1171-6. PubMed ID: 12115220 [TBL] [Abstract][Full Text] [Related]
5. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients. Gerloni V; Pontikaki I; Gattinara M; Fantini F Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916 [TBL] [Abstract][Full Text] [Related]
6. [The treatment of recurrent uveitis with TNF-alpha inhibitors]. Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524 [TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X; Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Tse SM; Burgos-Vargas R; Laxer RM Arthritis Rheum; 2005 Jul; 52(7):2103-8. PubMed ID: 15986366 [TBL] [Abstract][Full Text] [Related]
9. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Galor A; Perez VL; Hammel JP; Lowder CY Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012 [TBL] [Abstract][Full Text] [Related]
11. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis. Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515 [TBL] [Abstract][Full Text] [Related]
12. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863 [TBL] [Abstract][Full Text] [Related]
13. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Slifman NR; Gershon SK; Lee JH; Edwards ET; Braun MM Arthritis Rheum; 2003 Feb; 48(2):319-24. PubMed ID: 12571839 [TBL] [Abstract][Full Text] [Related]
14. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
15. [Longterm outcome of TNF blockade in adult-onset Still's disease]. Dechant C; Schauenberg P; Antoni CE; Kraetsch HG; Kalden JR; Manger B Dtsch Med Wochenschr; 2004 Jun; 129(23):1308-12. PubMed ID: 15179590 [TBL] [Abstract][Full Text] [Related]
17. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL; Watson KD; Silman AJ; Symmons DP; Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [TBL] [Abstract][Full Text] [Related]